Variant report

Variant	esv19367
Chromosome Location	chr11:45685695-45687403
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:28)
CpG islands
(count:488)
Chromatin interactive
region (count:0)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:28 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CHD1	chr11:45686332-45686365	H1-hESC	embryonic stem cell:	n/a	n/a
2	FOSL2	chr11:45685134-45685760	SK-N-SH	brain:	n/a	chr11:45685449-45685460 chr11:45685452-45685459 chr11:45685450-45685459
3	GABPA	chr11:45686131-45686403	H1-hESC	embryonic stem cell:	n/a	chr11:45686334-45686343 chr11:45686336-45686345 chr11:45686361-45686375
4	HMGN3	chr11:45686992-45687153	K562	blood:	n/a	n/a
5	JUND	chr11:45686285-45686294	H1-hESC	embryonic stem cell:	n/a	n/a
6	MYC	chr11:45686570-45686649	MCF-7	breast:	n/a	n/a
7	POLR2A	chr11:45686181-45687324	H1-neurons	neurons:	n/a	n/a
8	POLR2A	chr11:45686727-45687559	HUVEC	blood vessel:	n/a	n/a
9	POLR2A	chr11:45687265-45687269	MCF-7	breast:	n/a	n/a
10	POLR2A	chr11:45686300-45687317	H1-neurons	neurons:	n/a	n/a
11	POLR2A	chr11:45686898-45687270	HUVEC	blood vessel:	n/a	n/a
12	POLR2A	chr11:45687114-45687142	MCF-7	breast:	n/a	n/a
13	POLR2A	chr11:45687062-45687185	MCF-7	breast:	n/a	n/a
14	POLR2A	chr11:45685949-45686151	HUVEC	blood vessel:	n/a	n/a
15	POLR2A	chr11:45687098-45687107	MCF-7	breast:	n/a	n/a
16	POLR2A	chr11:45685802-45685866	HUVEC	blood vessel:	n/a	n/a
17	POLR2A	chr11:45687117-45687139	Gliobla	brain:	n/a	n/a
18	POLR2A	chr11:45687047-45687261	MCF-7	breast:	n/a	n/a
19	SIN3A	chr11:45685750-45686324	H1-hESC	embryonic stem cell:	n/a	n/a
20	SIN3A	chr11:45686546-45686661	H1-hESC	embryonic stem cell:	n/a	n/a
21	SIN3A	chr11:45686943-45687017	H1-hESC	embryonic stem cell:	n/a	n/a
22	TAF1	chr11:45686710-45687311	H1-neurons	neurons:	n/a	n/a
23	TBP	chr11:45686998-45687069	H1-hESC	embryonic stem cell:	n/a	n/a
24	UBTF	chr11:45687091-45687103	K562	blood:	n/a	n/a
25	ZBTB7A	chr11:45687159-45687665	ECC-1	luminal epithelium:	n/a	chr11:45687215-45687222
26	ZBTB7A	chr11:45687203-45687709	ECC-1	luminal epithelium:	n/a	chr11:45687215-45687222
27	ZBTB7A	chr11:45686374-45686868	ECC-1	luminal epithelium:	n/a	n/a
28	ZNF263	chr11:45686104-45687174	HEK293-T-REx	kidney:	n/a	chr11:45686877-45686898

(count:488 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:45687263-45687313	SKMC	muscle:	n/a
2	chr11:45687319-45687369	AG09319	gingival:	n/a
3	chr11:45687281-45687331	RPTEC	kidney:	n/a
4	chr11:45687281-45687331	NB4	blood:	n/a
5	chr11:45687263-45687313	HNPCEpiC	eye:	n/a
6	chr11:45687263-45687313	SK-N-MC	brain:	n/a
7	chr11:45687275-45687325	HEEpiC	esophagus:	n/a
8	chr11:45687319-45687369	SK-N-SH	brain:	n/a
9	chr11:45687275-45687325	PFSK-1	brain:	n/a
10	chr11:45686369-45686419	NB4	blood:	n/a
11	chr11:45687281-45687331	T-47D	breast:	n/a
12	chr11:45687055-45687105	K562	blood:	n/a
13	chr11:45687277-45687327	HCPEpiC	choroid plexus:	n/a
14	chr11:45687319-45687369	HCM	heart:	n/a
15	chr11:45687275-45687325	HL-60	blood:	n/a
16	chr11:45686055-45686105	AG09319	gingival:	n/a
17	chr11:45687275-45687325	Hepatocyte	liver:	n/a
18	chr11:45687319-45687369	HCT-116	colon:	n/a
19	chr11:45687275-45687325	HEK293	kidney:	embryo
20	chr11:45687055-45687105	GM06990	blood:	n/a
21	chr11:45687275-45687325	Jurkat	blood:	n/a
22	chr11:45687263-45687313	BJ	skin:	n/a
23	chr11:45686055-45686105	HRE	kidney:	n/a
24	chr11:45687277-45687327	GM12878	blood:	n/a
25	chr11:45687281-45687331	AoSMC	blood vessel:	n/a
26	chr11:45687319-45687369	AG09309	skin:	n/a
27	chr11:45687055-45687105	AG04450	lung:	fetal
28	chr11:45687281-45687331	AG09309	skin:	n/a
29	chr11:45687275-45687325	SAEC	small airway:	n/a
30	chr11:45687275-45687325	NB4	blood:	n/a
31	chr11:45687319-45687369	AG04450	lung:	fetal
32	chr11:45687281-45687331	Hela-S3	cervix:	n/a
33	chr11:45687275-45687325	LNCaP	prostate:	n/a
34	chr11:45687275-45687325	AG04449	skin:	fetal
35	chr11:45687277-45687327	HepG2	liver:	n/a
36	chr11:45687281-45687331	NHBE	bronchial:	n/a
37	chr11:45687281-45687331	K562	blood:	n/a
38	chr11:45686055-45686105	ovcar-3	ovarian:	n/a
39	chr11:45687281-45687331	ECC-1	luminal epithelium:	n/a
40	chr11:45686055-45686105	AG04449	skin:	fetal
41	chr11:45687275-45687325	HRCEpiC	kidney:	n/a
42	chr11:45687275-45687325	Hela-S3	cervix:	n/a
43	chr11:45687277-45687327	HCT-116	colon:	n/a
44	chr11:45687277-45687327	CMK	blood:	n/a
45	chr11:45686055-45686105	PrEC	prostate:	n/a
46	chr11:45687275-45687325	MCF10A-Er-Src	breast:	n/a
47	chr11:45686369-45686419	HEEpiC	esophagus:	n/a
48	chr11:45687055-45687105	T-47D	breast:	n/a
49	chr11:45687275-45687325	AG10803	skin:	n/a
50	chr11:45687277-45687327	ProgFib	skin:	n/a

No data

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C11orf94-5	chr11:45686728-45687144	NONHSAT019041

No data

Variant related genes	Relation type
CHST1	TF binding region
CHST1	CpG island

Extended variants
information (count: 59 )
Associated
traits (count: 58 )

Variant overlapped rSNPs/rCNVs (count:59 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs372981117	chr11:45685752-45685753	Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers Bivalent/Poised TSS Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs530312781	chr11:45685767-45685768	Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers Bivalent/Poised TSS Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs549027451	chr11:45685824-45685825	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
4	rs565698074	chr11:45685828-45685829	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
5	rs554921879	chr11:45685830-45685831	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
6	rs7947626	chr11:45685839-45685840	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs551508144	chr11:45685847-45685848	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
8	rs45564632	chr11:45685888-45685889	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs36106594	chr11:45685906-45685907	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs556863911	chr11:45685910-45685911	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
11	rs573909793	chr11:45685928-45685929	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
12	rs550367191	chr11:45685958-45685959	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
13	rs536166485	chr11:45686019-45686020	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
14	rs45538436	chr11:45686080-45686081	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs572912031	chr11:45686114-45686115	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
16	rs544957233	chr11:45686166-45686167	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
17	rs565085213	chr11:45686183-45686184	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
18	rs575639386	chr11:45686224-45686225	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
19	rs12362984	chr11:45686225-45686226	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs118130800	chr11:45686264-45686265	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
21	rs34264431	chr11:45686285-45686286	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs547329606	chr11:45686313-45686314	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
23	rs45476394	chr11:45686324-45686325	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs528093643	chr11:45686342-45686343	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
25	rs577474194	chr11:45686391-45686392	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
26	rs145873267	chr11:45686399-45686400	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
27	rs571355289	chr11:45686408-45686409	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
28	rs556168828	chr11:45686465-45686466	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
29	rs536728434	chr11:45686487-45686488	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
30	rs45554232	chr11:45686512-45686513	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs45604433	chr11:45686533-45686534	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs536001610	chr11:45686554-45686555	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
33	rs45486999	chr11:45686555-45686556	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs566427149	chr11:45686654-45686655	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs538686535	chr11:45686655-45686656	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs12804655	chr11:45686694-45686695	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs575721501	chr11:45686704-45686705	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs544400107	chr11:45686719-45686720	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs4756012	chr11:45686754-45686755	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
40	rs555010782	chr11:45686789-45686790	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
41	rs574941227	chr11:45686800-45686801	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
42	rs111825873	chr11:45686871-45686872	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
43	rs540781513	chr11:45686888-45686889	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
44	rs560810931	chr11:45686999-45687000	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
45	rs532841605	chr11:45687003-45687004	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
46	rs545052043	chr11:45687069-45687070	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
47	rs11549305	chr11:45687072-45687073	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs530493783	chr11:45687096-45687097	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
49	rs550414300	chr11:45687114-45687115	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
50	rs180758073	chr11:45687115-45687116	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:58)

Disease	PMID	Source
Parathyroid adenoma	22454399	CNVD
Medulloblastoma	21979893	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Medulloblastoma	16783165	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Chordoma	18071362	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21364760	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
small cell lung cancer	20016488	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Myelofibrosis	22110671	CNVD
Melanoma	18172304	CNVD
Intracranial ependymoma	16609018	CNVD
Myxofibrosarcoma	16751306	CNVD
Potocki-Shaffer syndrome	22470819	CNVD
Neurodevelopmental disorder	22521361	CNVD
Breast cancer	16608533	CNVD
Hirschsprung''s Disease	21712996	CNVD
Follicular lymphoma	20505157	CNVD
Colorectal cancer	21128281	CNVD
Breast cancer	20409316	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17160897	CNVD
Mantle cell lymphoma	19029149	CNVD
Glioblastoma multiforme	21138945	CNVD
Prostate cancer	18632612	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD

Chromatin state (count:361 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:45680000-45688000	Enhancers	Fetal Brain Male	brain
2	chr11:45680200-45686000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr11:45682000-45686200	Flanking Active TSS	Fetal Brain Female	brain
4	chr11:45682400-45686600	Bivalent Enhancer	Fetal Lung	lung
5	chr11:45682800-45685800	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
6	chr11:45682800-45685800	Bivalent Enhancer	Fetal Stomach	stomach
7	chr11:45682800-45685800	Enhancers	Lung	lung
8	chr11:45683000-45686200	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
9	chr11:45683400-45686000	Bivalent Enhancer	Placenta	Placenta
10	chr11:45683400-45686200	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
11	chr11:45683600-45685800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
12	chr11:45683800-45685800	Enhancers	A549	lung
13	chr11:45684000-45685800	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
14	chr11:45684200-45685800	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
15	chr11:45684200-45685800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
16	chr11:45684200-45685800	Bivalent Enhancer	Fetal Intestine Small	intestine
17	chr11:45684200-45686200	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
18	chr11:45684200-45686400	Flanking Active TSS	HUVEC	blood vessel
19	chr11:45684400-45686200	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
20	chr11:45684400-45686200	Enhancers	Placenta Amnion	Placenta Amnion
21	chr11:45684400-45686200	Bivalent Enhancer	NHLF	lung
22	chr11:45684600-45685800	Active TSS	Brain Angular Gyrus	brain
23	chr11:45684600-45686000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
24	chr11:45684600-45686600	Bivalent Enhancer	Fetal Thymus	thymus
25	chr11:45684800-45685800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
26	chr11:45684800-45685800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
27	chr11:45684800-45685800	Enhancers	Left Ventricle	heart
28	chr11:45684800-45686000	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
29	chr11:45684800-45686600	Flanking Bivalent TSS/Enh	Dnd41	blood
30	chr11:45685000-45685800	Bivalent Enhancer	Spleen	Spleen
31	chr11:45685000-45686000	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
32	chr11:45685000-45686000	Active TSS	Brain Anterior Caudate	brain
33	chr11:45685000-45686000	Enhancers	NH-A	brain
34	chr11:45685200-45685800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
35	chr11:45685200-45686000	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
36	chr11:45685200-45686200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
37	chr11:45685200-45686600	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
38	chr11:45685200-45686600	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
39	chr11:45685400-45685800	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
40	chr11:45685400-45685800	Bivalent/Poised TSS	Primary hematopoietic stem cells	blood
41	chr11:45685400-45685800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
42	chr11:45685400-45686000	Bivalent Enhancer	Adipose Nuclei	Adipose
43	chr11:45685400-45686000	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
44	chr11:45685400-45686000	Bivalent Enhancer	Duodenum Mucosa	Duodenum
45	chr11:45685400-45686000	Enhancers	Pancreas	Pancrea
46	chr11:45685400-45686000	Bivalent Enhancer	Osteobl	bone
47	chr11:45685400-45686200	Flanking Bivalent TSS/Enh	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
48	chr11:45685400-45686200	Bivalent Enhancer	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
49	chr11:45685400-45686200	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
50	chr11:45685400-45686200	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links